<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2 20190208//EN" "http://jats.nlm.nih.gov/publishing/1.2/JATS-journalpublishing1.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.2" xml:lang="en">
    <front>
        <journal-meta>
            <journal-id journal-id-type="pmc">F1000Research</journal-id>
            <journal-title-group>
                <journal-title>F1000Research</journal-title>
            </journal-title-group>
            <issn pub-type="epub">2046-1402</issn>
            <publisher>
                <publisher-name>F1000 Research Limited</publisher-name>
                <publisher-loc>London, UK</publisher-loc>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="doi">10.12688/f1000research.131728.1</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Research Article</subject>
                </subj-group>
                <subj-group>
                    <subject>Articles</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>
                    <italic>In silico</italic> identification of quorum sensing inhibitors against LasR protein in a clinical isolate of multidrug resistant 
                    <italic>Pseudomonas aeruginosa</italic> DMC-27b</article-title>
                <fn-group content-type="pub-status">
                    <fn>
                        <p>[version 1; peer review: 1 approved]</p>
                    </fn>
                </fn-group>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Siam</surname>
                        <given-names>Md. Hasanul Banna</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Data Curation</role>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Methodology</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Original Draft Preparation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-5883-2841</uri>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Sirajee</surname>
                        <given-names>Ahmad Salman</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Limon</surname>
                        <given-names>Md. Belayet Hasan</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Investigation</role>
                    <role content-type="http://credit.niso.org/">Visualization</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="no">
                    <name>
                        <surname>Hossain</surname>
                        <given-names>M. Anwar</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="aff" rid="a1">1</xref>
                    <xref ref-type="aff" rid="a2">2</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Sultana</surname>
                        <given-names>Munawar</given-names>
                    </name>
                    <role content-type="http://credit.niso.org/">Conceptualization</role>
                    <role content-type="http://credit.niso.org/">Supervision</role>
                    <role content-type="http://credit.niso.org/">Writing &#x2013; Review &amp; Editing</role>
                    <xref ref-type="corresp" rid="c1">a</xref>
                    <xref ref-type="aff" rid="a1">1</xref>
                </contrib>
                <aff id="a1">
                    <label>1</label>Department of Microbiology, University of Dhaka, Dhaka, 1000, Bangladesh</aff>
                <aff id="a2">
                    <label>2</label>Jessore University of Science and Technology, Jessore, 7408, Bangladesh</aff>
            </contrib-group>
            <author-notes>
                <corresp id="c1">
                    <label>a</label>
                    <email xlink:href="mailto:munawar@du.ac.bd">munawar@du.ac.bd</email>
                </corresp>
                <fn fn-type="conflict">
                    <p>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>12</day>
                <month>1</month>
                <year>2024</year>
            </pub-date>
            <pub-date pub-type="collection">
                <year>2024</year>
            </pub-date>
            <volume>13</volume>
            <elocation-id>62</elocation-id>
            <history>
                <date date-type="accepted">
                    <day>15</day>
                    <month>5</month>
                    <year>2023</year>
                </date>
            </history>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Siam MHB et al.</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <self-uri content-type="pdf" xlink:href="https://f1000research.com/articles/13-62/pdf"/>
            <abstract>
                <p>
                    <bold>Background:</bold> 
                    <italic toggle="yes">Pseudomonas aeruginosa</italic> is an opportunistic pathogen that uses quorum-sensing (QS) and biofilm formation to subvert antibiotic therapy. Antibiotic resistance has led to a demand for alternative methods of treatment, and destabilizing the LasR-OdDHL binding with inhibitors offers a potential solution.</p>
                <p>
                    <bold>Methods:</bold> This study aimed to construct a homology model of the LasR protein using the genetic sequence of the 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b strain (GenBank: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2">SMRY00000000.2</ext-link>). Molecular docking, molecular mechanics-based binding free energy calculation, and pharmacokinetic analysis were performed on 1900 3D structures collected from synthetic and natural compound databases to identify three potential lead molecules. These compounds were evaluated using ADMET (absorption, distribution, metabolism, excretion, toxicity) analysis, and molecular dynamics protocols were used to refine the results.</p>
                <p>
                    <bold>Results:</bold> The three lead compounds showed higher binding capability with the LasR receptor than the native ligand and passed the ADMET evaluation stage. In total, 44 properties remained within the range of 95% of known drugs, indicating their potential efficacy as drugs against 
                    <italic toggle="yes">P. aeruginosa</italic> and other bacteria that use a similar QS system.</p>
                <p>
                    <bold>Conclusions:</bold> This study provides insights into potential drug designing and development against clinical isolates of emerging 
                    <italic toggle="yes">P. aeruginosa</italic> strains and other bacteria that use a similar QS system.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <kwd>Quorum sensing</kwd>
                <kwd>Virtual screening</kwd>
                <kwd>Pseudomonas</kwd>
                <kwd>Antibiotic resistance</kwd>
                <kwd>Docking</kwd>
            </kwd-group>
            <funding-group>
                <funding-statement>The author(s) declared that no grants were involved in supporting this work.</funding-statement>
            </funding-group>
        </article-meta>
    </front>
    <body>
        <p>
            <def-list>
                <title>Abbreviations</title>
                <def-item>
                    <term id="G1">AHL</term>
                    <def>
                        <p>Acyl-Homoserine Lactone</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G2">HTVS</term>
                    <def>
                        <p>High Throughput Virtual Screening</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G4">MD</term>
                    <def>
                        <p>Molecular dynamics</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G3">MDR</term>
                    <def>
                        <p>Multi-Drug Resistant</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G5">MM-GBSA</term>
                    <def>
                        <p>Molecular mechanics-Generalized Born Surface Area</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G6">QS</term>
                    <def>
                        <p>Quorum Sensing</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G7">RAST</term>
                    <def>
                        <p>Rapid Annotation using Subsystem Technology</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G8">SDF</term>
                    <def>
                        <p>Structure-Data File</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G9">SANCDB</term>
                    <def>
                        <p>South African Natural Compounds Database</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G10">SGB</term>
                    <def>
                        <p>Surface Generalized Born</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G11">SP</term>
                    <def>
                        <p>Standard Precision</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G12">UTI</term>
                    <def>
                        <p>Urinary Tract Infection</p>
                    </def>
                </def-item>
                <def-item>
                    <term id="G13">XP</term>
                    <def>
                        <p>Extra-Precision</p>
                    </def>
                </def-item>
            </def-list>
        </p>
        <sec id="sec1" sec-type="intro">
            <title>Introduction</title>
            <p>
                <italic toggle="yes">Pseudomonas aeruginosa</italic>, a species of considerable medical interest, is wreaking havoc in humans due to its wide role in infections. This encapsulated, gram-negative, rod-shaped bacterium has emerged as a multidrug-resistant superbug rendering antibiotics ineffective during treatment (
                <xref ref-type="bibr" rid="ref17">Lyczak 
                    <italic toggle="yes">et al</italic>., 2002</xref>). The opportunistic bacterium causes a plethora of diseases including cystic fibrosis, urinary tract infection, acute leukemia, endocarditis, meningitis, pneumonia, and septicemia (
                <xref ref-type="bibr" rid="ref3">Bodey 
                    <italic toggle="yes">et al</italic>., 1983</xref>). The infections are more common in immunocompromised patients &#x2013; making 
                <italic toggle="yes">P. aeruginosa</italic> the second most common organism isolated in nosocomial pneumonia (17% of cases) and the third most common organism isolated in both urinary tract infection (UTI) and surgical site infection (11% of cases) (
                <xref ref-type="bibr" rid="ref27">Richards 
                    <italic toggle="yes">et al</italic>., 1999</xref>). As a mechanism of antibiotic resistance, the bacteria can form slime-enclosed biofilms as a protective barrier (
                <xref ref-type="bibr" rid="ref17">Lyczak 
                    <italic toggle="yes">et al</italic>., 2002</xref>). The development of biofilm is closely connected to another process termed as Quorum Sensing (QS) (
                <xref ref-type="bibr" rid="ref32">Solano 
                    <italic toggle="yes">et al</italic>., 2014</xref>). QS is a cell-to-cell communication process through which bacteria can sense population density and regulate gene expression accordingly. Biofilm development, biofilm dispersion and upregulation of the synthesis of surfactant molecules are deeply intertwined with QS circuit (
                <xref ref-type="bibr" rid="ref15">Lee &amp; Zhang, 2014</xref>).</p>
            <p>There are four QS systems in 
                <italic toggle="yes">P. aeruginosa</italic>, namely Las, RhI, Pqs and Iqs (
                <xref ref-type="bibr" rid="ref29">Scoffone 
                    <italic toggle="yes">et al</italic>., 2019</xref>). The Las remains at the top of the circuit in the hierarchy and is comprised of LasI and LasR &#x2013; the former synthesizing an autoinducer molecule i.e. 
                <italic toggle="yes">N-(3-oxododecanoyl)-L-homoserine lactone</italic> or OdDHL, and the latter receiving the OdDHL to carry out transcriptional regulation (
                <xref ref-type="bibr" rid="ref15">Lee &amp; Zhang, 2014</xref>). The binding of OdDHL to LasR initiates the cascade of signals that regulate further signaling in Rhl, Pqs and Iqs systems. The quorum sensing network in 
                <italic toggle="yes">Pseudomonas aeruginosa</italic> also employs three other signaling molecules: 
                <italic toggle="yes">N-butyryl-L-homoserine lactone</italic> (BHL) synthesized by the RhlI AHL (
                <italic toggle="yes">Acyl-Homoserine Lacton</italic>e) synthase which binds to the RhlR receptor; 
                <italic toggle="yes">2-heptyl-3-hydroxy-4(1H)-quinolone</italic> (PSQ) binds to PqsR; and 
                <italic toggle="yes">2-(2-hydroxyphenyl)-thiazole-4-carbaldehyde</italic> (IQS) binds to IqsR. The two receptors, LasR and RhIR, are transcriptional regulators that regulate the expression of nearly 300 genes of 
                <italic toggle="yes">P. aeruginosa</italic> genome (
                <xref ref-type="bibr" rid="ref5">Feltner 
                    <italic toggle="yes">et al</italic>., 2016</xref>). The LasR protein has two domains: ligand-binding and DNA-binding. When OdDHL binds to the LasR receptor, it binds to the ligand-binding domain and activates the protein. Consequently, the DNA-binding domain attaches to the target DNA to regulate the transcription. The production of rhamnolipids and the virulence factors such as elastase, exoprotease, pyocyanin are all regulated and influenced by the initial interaction and complex formation of LasR/OdDHL (
                <xref ref-type="bibr" rid="ref21">Ochsner 
                    <italic toggle="yes">et al</italic>., 1995</xref>).</p>
            <p>The search for potential quorum sensing inhibitors (QSI) has been of great interest and research showed that QSI could compete against the native ligand for binding with LasR and disrupt the QS-signaling cascade and the subsequent biofilm formation (
                <xref ref-type="bibr" rid="ref1">Annapoorani 
                    <italic toggle="yes">et al</italic>., 2012</xref>; 
                <xref ref-type="bibr" rid="ref34">Zeng 
                    <italic toggle="yes">et al</italic>., 2008</xref>). The LasR inhibitors can be classified into three classes: non-AHL-like antagonists, AHL-like antagonists, and covalent binders (
                <xref ref-type="bibr" rid="ref29">Scoffone 
                    <italic toggle="yes">et al</italic>., 2019</xref>). Both natural products and synthetic compounds have been researched for potential candidates. A recent study has found two potential chemical compounds that can work as quorum sensing inhibitors (
                <xref ref-type="bibr" rid="ref20">Nain 
                    <italic toggle="yes">et al</italic>., 2019</xref>). In another study, a halogenated furanone compound from a marine alga 
                <italic toggle="yes">Delisea pulchra</italic> was shown to have good anti-QS property (
                <xref ref-type="bibr" rid="ref22">O&#x2019;Loughlin 
                    <italic toggle="yes">et al</italic>., 2013</xref>). But most of the halogenated furanone is reactive and hence too toxic to be used for treatment in human (
                <xref ref-type="bibr" rid="ref8">Hentzer &amp; Givskov, 2003</xref>). There are other natural products having anti-QS activity such as patulin, penicillic acid from 
                <italic toggle="yes">Penicillium</italic> species (
                <xref ref-type="bibr" rid="ref26">Rasmussen 
                    <italic toggle="yes">et al</italic>., 2005</xref>), ajoene, a sulfur-rich molecule from garlic (
                <xref ref-type="bibr" rid="ref11">Jakobsen 
                    <italic toggle="yes">et al</italic>., 2012</xref>), ellagic acid derivatives from 
                <italic toggle="yes">Terminalia chebula</italic> Retz (
                <xref ref-type="bibr" rid="ref28">Sarabhai 
                    <italic toggle="yes">et al</italic>., 2015</xref>), and Coumarin. Coumarin is obtained from plant extract and it has strong anti-virulence activity. It is also effective against protease and pyocyanin production and it blocks biofilm formation (
                <xref ref-type="bibr" rid="ref19">Monte 
                    <italic toggle="yes">et al</italic>., 2014</xref>).</p>
            <p>In our study, we used 
                <italic toggle="yes">Pseudomonas aeruginosa</italic> DMC-27b (GenBank: 
                <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2">SMRY00000000.2</ext-link>), a clinical strain isolated from a urine sample of an ICU patient at Dhaka Medical College hospital, Bangladesh. The original data collection took place as part of a previous study by our lab (
                <xref ref-type="bibr" rid="ref10">Jahan 
                    <italic toggle="yes">et al</italic>., 2020</xref>), and the strain was found to be resistant against a total of 20 antibiotics with having chromosomal inheritance of all four classes of beta-lactamases (
                <xref ref-type="bibr" rid="ref10">Jahan 
                    <italic toggle="yes">et al</italic>., 2020</xref>). The significance of using this Multi-Drug Resistant (MDR) isolate from Bangladesh offers an opportunity for a case study and investigate into any possible mutation in the LasR protein that might have an impact on the ligand binding modes. Considering the emergence of new MDR 
                <italic toggle="yes">Pseudomonas. aeruginosa</italic> strains across the globe, and how south Asian countries like Bangladesh are acting as epicenters of AMR (Antimicrobial resistance) spread, it is critical to survey changes in the LasR receptor and continue to enrich the pool of new inhibitors.</p>
        </sec>
        <sec id="sec2" sec-type="methods">
            <title>Methods</title>
            <sec id="sec3">
                <title>Experimental workflow</title>
                <p>The cheminformatics analyses were carried out in 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/maestro">Schrodinger Maestro</ext-link> v11.8 (Schrodinger, LLC, New York, NY. There is a free academic version of this license that can be used to replicate this work. In addition, readers can use 
                    <ext-link ext-link-type="uri" xlink:href="https://vina.scripps.edu/">AutoDock Vina</ext-link> as an alternative software that carries out a similar function). This study utilised a desktop PC with Intel (R) Core&#x2122; i7 7700/4.0GHz processor, 8GB DDR4/3200 MHz RAM, and 4GB AMD Radeon RX 570 graphics with support for OpenCL 2.0 running Windows 10 Professional operating system. The entire workflow was segregated into three stages (
                    <xref ref-type="fig" rid="f1">Figure 1</xref>). Stage-I included genome retrieval and annotation, gene profiling, homology modeling of protein, and database search for AHL-like compounds. The stage-II included the protein and compounds preparation leading to molecular docking, molecular mechanics based binding free energy calculation. Stage-III began with further analysis comprising of ADMET analysis, induced fit docking and molecular dynamics. Finally, the lead compounds were comparatively analyzed with respect to the protein from the reference strain.</p>
                <fig fig-type="figure" id="f1" orientation="portrait" position="float">
                    <label>Figure 1. </label>
                    <caption>
                        <title>Experimental workflow of the study.</title>
                        <p>SP, Standard Precision; XP, Extra-Precision; MM-GBSA, Molecular mechanics-Generalized Born Surface Area; ADMET, absorption, distribution, metabolism, excretion, toxicity; RAST, Rapid Annotation using Subsystem Technology.</p>
                    </caption>
                    <graphic id="gr1" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure1.gif"/>
                </fig>
            </sec>
            <sec id="sec4">
                <title>Retrieval of genome and annotation</title>
                <p>The genomic data were retrieved from National Center for Biotechnology Information (
                    <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/">NCBI</ext-link>) for the strain 
                    <italic toggle="yes">Pseudomonas aeruginosa</italic> DMC-27b with the GenBank accession number 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2">SMRY00000000.2</ext-link> (
                    <xref ref-type="bibr" rid="ref25">Pseudomonas Aeruginosa Strain DMC-27b, Whole Genome Shotgun Sequencing Project, 2019</xref>). The raw data was uploaded to the publicly available web server 
                    <ext-link ext-link-type="uri" xlink:href="https://rast.nmpdr.org/">RAST</ext-link> (Rapid Annotation using Subsystem Technology) for automatic annotation. The presence of LasI/LasR and the proteins involved in the QS system were confirmed by RAST and were furthered validated by custom Basic Local Alignment Search Tool (
                    <ext-link ext-link-type="uri" xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi">BLAST</ext-link>) searches inside the RAST SEED viewer version 2.0 (
                    <xref ref-type="bibr" rid="ref23">Overbeek 
                        <italic toggle="yes">et al</italic>., 2014</xref>).</p>
            </sec>
            <sec id="sec5">
                <title>Protein homology modeling</title>
                <p>The amino acid sequence of the LasR protein of 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b was submitted to the publicly available 
                    <ext-link ext-link-type="uri" xlink:href="https://swissmodel.expasy.org/">SWISS-MODEL</ext-link> web server for homology modelling (
                    <xref ref-type="bibr" rid="ref33">Waterhouse 
                        <italic toggle="yes">et al</italic>., 2018</xref>). The protein template PDB: 
                    <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/structure/3IX3">3IX3</ext-link> was selected owing to its high resolution (i.e. 1.4 &#x00c5;), standard range R-free value (i.e. 0.207) and an excellent score in Ramachandran outliers (i.e. 0.0%). The generated 3D homology model (created using SWISS-MODEL) was created in homodimer containing two chains: A and B and both contained the co-crystallized ligands. The quality of the resulting protein structure was validated using QMEAN-Z score and Ramachandran plot analysis.</p>
            </sec>
            <sec id="sec6">
                <title>Database search for AHL-like compounds</title>
                <p>The original ligand (i.e. N-3-Oxo-Dodecanoyl-L-Homoserine Lactone) for the LasR protein was used to observe the protein-ligand interaction, and to identify the core structure of the ligand. A total of three chemical databases were used to download chemical compounds. 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/">PubChem</ext-link> (
                    <xref ref-type="bibr" rid="ref14">Kim 
                        <italic toggle="yes">et al</italic>., 2019</xref>) and 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/chembl/">ChEMBL</ext-link> (
                    <xref ref-type="bibr" rid="ref4">Davies 
                        <italic toggle="yes">et al</italic>., 2015</xref>) were used to find and download chemical structures similar to N-3-Oxo-Dodecanoyl-L-Homoserine Lactone. Next, a complete 
                    <ext-link ext-link-type="uri" xlink:href="https://sancdb.rubi.ru.ac.za/">SancDB</ext-link> database was downloaded (
                    <xref ref-type="bibr" rid="ref7">Hatherley 
                        <italic toggle="yes">et al</italic>., 2015</xref>) in the form of SANCDB SDF structure PubChem is a massive open repository of experimental data and ChEMBL is a manually curated chemical database of compounds with drug-like properties. SancDB, which stands for South African Natural Compounds Database, is a database containing compounds isolated from the plant and marine life in and around South Africa. PubChem and ChEMBL returned 1080 compounds, and SancDB returned 820 compounds totaling the number of compounds to reach 1900 - see 
                    <italic toggle="yes">Underlying data</italic> (
                    <xref ref-type="bibr" rid="ref31">Siam, 2023</xref>) for the full list (re-uploading permissible under copyright).</p>
            </sec>
            <sec id="sec7">
                <title>Protein preparation</title>
                <p>The protein model (LasR_DMC27b.pdb, generated using SWISS-MODEL by keeping 3IX3 as a reference) was not suitable for molecular docking in its unprepared state (
                    <xref ref-type="bibr" rid="ref13">Kalia 
                        <italic toggle="yes">et al</italic>., 2017</xref>) because an unprepared protein structure may contain gaps, missing atoms, and other structural irregularities that may affect the accuracy of the docking simulation. The protein structure was prepared by Schrodinger&#x2019;s Protein Preparation Wizard (part of Schrodinger Maestro). During preparation, proper bond orders were assigned, hydrogens atoms and missing residues were added, water molecules beyond 5.00 &#x00c5; distance were removed from hetero groups, and hetero states were generated using Epik at pH: 7.0 &#x00b1; 2.0. The protein was further refined by optimizing the H-bond assignment and running restrained energy minimization of the structure using force field Optimized Potentials for Liquid Simulations (version OPLS_2005) until the heavy atoms converged to the RMSD value of 0.30 &#x00c5; (
                    <xref ref-type="bibr" rid="ref2">Banks 
                        <italic toggle="yes">et al</italic>., 2005</xref>).</p>
            </sec>
            <sec id="sec8">
                <title>Compounds preparation</title>
                <p>All the selected 1900 compounds were downloaded in their three-dimensional structure-data file (SDF) format. A phase database was created using Schrodinger Maestro v11.8 to assemble the potential ligand-like compounds. The Schrodinger 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/ligprep">LigPrep</ext-link> v2.2 module (part of Schrodinger Maestro) was applied to generate tautomers and ionization states at pH: 7 &#x00b1; 2.0 and to minimize energy using force field OPLS_2005. The Epik v4.6 (part of Schrodinger Maestro) was used to compute the predicted pKa values for drug-like molecules; and reactive functional groups were eliminated from the result which might give false positive during screening (
                    <xref ref-type="bibr" rid="ref30">Shelley 
                        <italic toggle="yes">et al</italic>., 2007</xref>). To filter the unsuitable compounds, Schrodinger 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/qikprop">QikProp</ext-link> module (part of Schrodinger Maestro) was applied to test the Lipinski&#x2019;s Rule of five (
                    <xref ref-type="bibr" rid="ref16">Lipinski 
                        <italic toggle="yes">et al</italic>., 2001</xref>) and Jorgensen&#x2019;s rule of three (
                    <xref ref-type="bibr" rid="ref12">Jorgensen, 2004</xref>).</p>
            </sec>
            <sec id="sec9">
                <title>Receptor grid generation</title>
                <p>The grid-box was generated using the Schrodinger Glide v8.1 module (part of Schrodinger Maestro) based on the co-crystallized ligand structure in LasR-DMC27b PDB model. For flexible docking, the active site was confined to a larger enclosing box in proportion to the defined smaller box (27&#x00d7;27&#x00d7;27 &#x00c5;) around the potential binding site of interest using the centroid native ligand. The Van der Waals radius scaling factor was set to 1.0 &#x00c5; and the partial charge cutoff was kept at 0.25. There was no constraint or rotatable group set during the grid-box generation.</p>
            </sec>
            <sec id="sec10">
                <title>Molecular docking</title>
                <p>The Schrodinger 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/glide">Glide</ext-link> v8.1 was used to run Standard Precision (SP) docking for 1900 compounds employing the generated receptor grid (
                    <xref ref-type="bibr" rid="ref6">Friesner 
                        <italic toggle="yes">et al</italic>., 2004</xref>). Based on the literature review, an initial cutoff value of -7.5 kcal/mol was considered for filtering which returned 270 compounds (
                    <xref ref-type="bibr" rid="ref20">Nain 
                        <italic toggle="yes">et al</italic>., 2019</xref>). For the second phase, the compounds were docked using XP (Extra Precision) method and this time, the cutoff value was set to -8.75 since the native ligand (OdDHL) binds to the LasR_DMC27b with an XP score of -8.72 kcal/mol. In both cases, the flexible ligand sampling scheme was used. Compounds with more than 500 atoms and 1000 rotatable bonds were skipped and Epik state penalty was added to the docking score. In post docking minimization, the number of poses per compound was set to five. After XP docking, a total of 45 compounds were assessed comprising of different variations of PubChem compounds: 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/138105963">K5D</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/130387784">K5G</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/137628325">K5J</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/945">OHN</ext-link>, and 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/443433">443433</ext-link>.</p>
            </sec>
            <sec id="sec11">
                <title>Molecular mechanics-based end-point binding free energy calculation</title>
                <p>The 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/prime">Schrodinger Prime</ext-link> v3.3 [Prime, Schr&#x00f6;dinger, LLC, New York, NY, 2019], part of Schrodinger Maestro, was used to calculate MM-GBSA (Molecular Mechanics-Generalized Born Surface Area) based End-Point Binding Free Energy Calculation, which is an algorithmically rigorous, computationally intensive and superior to molecular docking. The MMGBSA methodology yields a credible assessment of binding free energy, expressed in Kcal/mol units, and may serve as a suitable approach for post-docking validation purposes. Here, GBSA continuum solvent model, as outlined in the work of (
                    <xref ref-type="bibr" rid="ref18">Lyne 
                        <italic toggle="yes">et al</italic>., 2006</xref>), was utilized to conduct simulations on a set of 45 compounds. Schrodinger Prime incorporates a surface generalized Born (SGB) model that utilizes a Gaussian surface in place of the Van der Waals surface to enable a more accurate representation of the solvent accessible surface area. Subsequent to the docking procedure, the binding free energy (&#x0394;G
                    <sub>bind</sub>) for each compound was calculated. Schrodinger Prime uses a surface generalized Born (SGB) model employing a Gaussian surface instead of Van der Waals surface for better representation of a solvent accessible surface area. Based on the docked complex, the binding free energy (&#x0394;G
                    <sub>bind</sub>) of each compound was calculated. All 45 compounds showed lower binding free energy than the native ligand, thus validating the result of XP docking.</p>
            </sec>
            <sec id="sec12">
                <title>ADMET prediction</title>
                <p>The 45 selected compounds were tested for drug-likeness and ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties using the Schrodinger QikProp v5.8 module (
                    <xref ref-type="bibr" rid="ref9">Ioakimidis 
                        <italic toggle="yes">et al</italic>., 2008</xref>). The druggability prediction is a crucial step in filtering the compounds that might be unsuitable for use in the human body. Unlike fragment-based approaches, QikProp&#x2019;s predictions are based on the full 3D molecular structure, providing accurate results on par with the properties of the 95% of known drugs. The QikProp&#x2019;s result yielded 44 properties for the chemical compounds, of which, ADMET properties and molecular descriptors were taken into consideration particularly octanol/water and water/gas log Ps, log S, log BB, overall CNS activity, Caco-2 and MDCK cell permeabilities, log Khsa for human serum albumin binding, HumanOralAbsorption and log IC50 for HERG K+-channel blockage. Since most halogenated furanone compounds are too reactive for use as drugs for their high electrophilicity, they were carefully removed from the result letting only 3 compounds to pass through the filters based on the QikProp&#x2019;s results.</p>
            </sec>
            <sec id="sec13">
                <title>Molecular dynamics</title>
                <p>The stability and intermolecular interactions between protein and molecules were investigated using molecular dynamics (MD) simulation (
                    <xref ref-type="bibr" rid="ref36">Liu &amp; Kokubo, 2017</xref>) techniques with a 100 ns time interval using the complexes obtained from docking studies to further investigate the protein and ligand binding mode. MD simulations were run with the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.schrodinger.com/products/desmond">Desmond module</ext-link> from the Schr&#x00f6;dinger Release 2020-4 (Academic edition) suite (Molecular dynamics can also be done using 
                    <ext-link ext-link-type="uri" xlink:href="https://www.gromacs.org/">GROMACS</ext-link> which is free to use). A TIP3P water model (density: 0.997 g/L) at physiological conditions (298 K, pH 7.4) with an orthorhombic box shape as the boundary was used to represent the complex protein-ligand interaction (
                    <xref ref-type="bibr" rid="ref35">Mark &amp; Nilsson, 2001</xref>). On all three axes, the minimum distance between the protein surface and the boundary was set to 10 &#x00c5;. The system was neutralized by adding 0.15 M Na+ and Cl- salt concentrations (
                    <xref ref-type="bibr" rid="ref37">Paul 
                        <italic toggle="yes">et al</italic>., 2023</xref>). Before simulation, NPT parameters (constant particle number (N), pressure (P), and temperature (T)) are utilized representing an isothermal-isobaric ensemble, which simulates the most typical experimental conditions. The MD simulation was run with the OPLS-2005 force field at constant pressure (1.01325 bar) and temperature (310 K), with recording intervals of 100 ps. These simulation conditions were set to mimic human cell microenvironment. The Simulation Interaction Diagram (SID) of the Desmond module of the Schr&#x00f6;dinger program was used to analyze the trajectories acquired from the MD simulation. Based on the simulated trajectories, root-mean-square deviation (RMSD), root-mean-square fluctuation (RMSF), and Protein-Ligand interactions were utilized to assess the stability of the ligand-protein complexes.</p>
            </sec>
            <sec id="sec14">
                <title>Comparative docking analysis</title>
                <p>A comparative docking analysis between our laboratory strain and the NCBI reference strain was done. The LasR_DMC27b.pdb was obtained from 
                    <italic toggle="yes">Pseudomonas aeruginosa</italic> DMC27b and the reference protein 3IX3 was obtained from 
                    <italic toggle="yes">Pseudomonas aeruginosa</italic> PAO1 and downloaded from the 
                    <ext-link ext-link-type="uri" xlink:href="https://www.rcsb.org/">Protein Data Bank (PDB</ext-link>). The selected inhibitors were used against the reference protein 3IX3. Molecular docking and MMGBSA were performed in case of both proteins using the selected compounds and the native ligand for comparison.</p>
            </sec>
        </sec>
        <sec id="sec15" sec-type="results|discussion">
            <title>Results and discussion</title>
            <sec id="sec16">
                <title>Proteins in the QS network</title>
                <p>The quorum-sensing circuit in 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b showed substantial resemblance to 
                    <italic toggle="yes">P. aeruginosa</italic> PAO1 except for RhlL and PhzD proteins. All the required proteins responsible for QS were found to exist in 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b indicating capacity for quorum sensing and biofilm formation. The presence of LasI, LasR, RhlR, RhlI and RhlL were manually confirmed by BLASTp search. The activation of the Las system further activates the Rhl system that produces rhamnolipids for which the contributing proteins (RhlI, RhlR, RhlA, RhlB, RhlC, RhlE, RhlL, RhlG) were all present in the 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b. A notable difference was found in Rhl system as 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b had both Rhl-I and Rhl-L proteins that contribute to N-butyryl-L-homoserine lactone synthesis and N-acyl-L-homoserine lactone synthesis, respectively. This property might provide the bacteria with an evolutionary advantage over the reference strain (PAO1) as the Rhl system can make use of quorum sensing signals by generating both types of homoserine lactones. Similarly, the absence of PhzI in the phenazine system indicates that the PhzR could be co-activated by different acyl-homoserine lactones. The production of exoprotease (encoded by lasA), elastase (encoded by lasB), biofilm dispersal mediator (C-di-GMP binding protein), the regulator of hydrogen cyanide synthase (ANR) were also present that play role in virulence. In the Phz system, PhzR was present, but the PhzI was not identified.</p>
            </sec>
            <sec id="sec17">
                <title>Protein homology model</title>
                <p>The quality of the resulting protein homology structure (denoted here as LasR_DMC27b) was checked and the QMEAN-Z score was 0.99 and the all-atom score was 1.92. One mutation was reported in the ligand-binding domain at the position of amino acid no. 171 (Glycine instead of Valine) and it was further confirmed by way of 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/Tools/psa/emboss_matcher/">EMBOSS</ext-link> matcher 6.6.0. The LasR protein has two domains: amino-terminal ligand-binding domain and a carboxy-terminal DNA-binding domain. The mutation in our strain is at the position of amino acid no. 171 (Glycine instead of Valine) at the terminal region, far away from its natural active site, hence it might not have considerable effect on the ligand-binding activity as seen from our study. The solvation and torsion scores were within an acceptable range. In Ramachandran Plot analysis, the number of residues in the favored region was 319 (99.1%); the number of residues in the allowed region was 3 (0.9%); and the percentage of outlier was 0.0% (
                    <xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
                <fig fig-type="figure" id="f2" orientation="portrait" position="float">
                    <label>Figure 2. </label>
                    <caption>
                        <title>The representation of Ramachandran Plot of homology model, and the Pairwise alignment between the LasR_DMC27b and the reference protein 3IX3.</title>
                        <p>(A) In Ramachandran Plot, about 99% of residues are in the favored region with 0.0% outliers. The image is generated and viewed using SWISS PDB viewer. (B) the Pairwise Alignment between LasR_DMC27b &amp; 3IX3 has Identity: 171/172 (99.4%), Gaps:1/172 (0.6%), and Score: 892; performed using EMBOSS matcher 6.6.0.</p>
                    </caption>
                    <graphic id="gr2" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure2.gif"/>
                </fig>
            </sec>
            <sec id="sec18">
                <title>Identification of inhibitors</title>
                <p>Three compounds were obtained as potential inhibitors denoted as L1, L2 and L3 after sequential identification process in order of- molecular docking, MMGBSA, molecular dynamics, ADMET prediction and were further improved with induced fit docking.</p>
            </sec>
            <sec id="sec19">
                <title>Molecular docking: SP and XP studies</title>
                <p>There was slight difference in the SP and XP docking scores of the selected compounds. All three compounds (L1, L2. L3) showed higher scores in SP, XP docking compared to the native ligand (OdDHL). The molecular docking result is shown in 
                    <xref ref-type="table" rid="T1">Table 1</xref>. The extra precision (XP) docking score for the OdDHL was found to be about -8.7 kcal/mol which is on par with other studies (
                    <xref ref-type="bibr" rid="ref20">Nain 
                        <italic toggle="yes">et al</italic>., 2019</xref>). All three selected compounds showed better binding capacity against both the clinical strain (i.e. DMC27b) and the reference strain (i.e. PAO1). The potential compounds showed greater free binding energy than the native ligand and had reasonable ligand strain energy. The compound L2 and L3 had variation in ligand strain energy, 5.198 kcal/mol and 8.041 kcal/mol, respectively, despite having a very similar nature of chemical structures.</p>
                <table-wrap id="T1" orientation="portrait" position="float">
                    <label>Table 1. </label>
                    <caption>
                        <title>Molecular docking studies of the three selected compounds against the LasR_DMC27b receptor.</title>
                        <p>IUPAC, The International Union of Pure and Applied Chemistry; SP, Standard Precision; XP, Extra-Precision.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Compound (PubChemID)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">IUPAC Name</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">SP-docking (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">XP-docking (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Glide Energy</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">HB (n)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Residues involved in H-bonds</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L1 (119321904)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">N-[2-[2-(3-Bromophenoxy) ethylsulfanyl]ethyl]pyrrolidine-2-carboxamide</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-11.35</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.46</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-59.40</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L2 (119321914)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">(2S)-2-Amino-N-[2-[2-(3-bromophenoxy)ethylsulfanyl]ethyl]-3-methylbutanamide</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-10.31</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.42</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-59.47</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L3 (119321910)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">2-Amino-N-[2-[2-(3-bromophenoxy) ethylsulfanyl]ethyl]pentanamide</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-10.71</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-11.76</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-55.39</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">OdDHL (3246941)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">N-3-Oxo-Dodecanoyl-L-Homoserine Lactone)</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-6.24</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-8.68</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-57.29</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp60</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>In the binding mode analysis, the selected compounds were well within the protein&#x2019;s active site. Compounds no. L1, L2 and L3 showed similar patterns of hydrogen bond interaction (
                    <xref ref-type="fig" rid="f3">Figure 3</xref>). The potential quorum-sensing inhibitors (QSI) were bound to the protein&#x2019;s active site by way of hydrogen bonds to the amino acids Tyr56, Ser129, Asp73 and Trp88. This showed a crucial difference in comparison to the native ligand (OdDHL) which binds to the protein using Tyr56, Ser129, Asp73 and Trp60 (
                    <xref ref-type="table" rid="T1">Table 1</xref>). Furthermore, LasR can bind an array of compounds containing the lactone head ring. Furthermore, the primary binding site for OdDHL is a combination of hydrophilic and hydrophobic interactions where the lactone head group facilitates hydrogen bonds stabilizing the structure while the acyl tail contributes to hydrophobic interactions. Reports show that LasR has two binding modes: one that mimics the canonical autoinducer binding arrangement, and the other with the lactone head group rotated approximately 150&#x00b0; (
                    <xref ref-type="bibr" rid="ref24">Paczkowski 
                        <italic toggle="yes">et al</italic>., 2019</xref>). The selected three compounds lack the lactone head group but facilitate strong hydrogen bonds with the receptor. All the compounds hydrogen-bonded with Tyr56, Ser129, Asp73 and Trp88. The tyrosine-56 and Serine-129 are the two most defining amino acid residues for LasR binding to its ligand. But, the native ligand binds with the receptor using Tyr56, Ser129, Asp73 and Trp60 instead of Trp88 found in the L1, L2 &amp; L3 inhibitors. This difference in the binding mode of the potential inhibitors could play a key role in inhibiting the quorum sensing signaling.</p>
                <fig fig-type="figure" id="f3" orientation="portrait" position="float">
                    <label>Figure 3. </label>
                    <caption>
                        <title>The molecular interactions between the LasR receptor and compounds.</title>
                        <p>(A) Compound L1 hydrogen-bonded with Tyr56, Ser129, Asp73, Trp88 residues of the LasR receptor. Similarly, (B) Complex-L2 showed HB interactions with Tyr56, Ser129, Asp73, Trp88 residue, and (C) Complex-L3 shared HBs with Tyr56, Ser129, Asp73, Trp88 residues, and (D) the reference compound shared HBS with Tyr56, Ser129, Asp73, and Trp60 residues.</p>
                    </caption>
                    <graphic id="gr3" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure3.gif"/>
                </fig>
            </sec>
            <sec id="sec20">
                <title>Prime MM-GBSA calculation</title>
                <p>In the MMGBSA analysis, the three compounds showed lower binding free energy than the native ligand (
                    <xref ref-type="table" rid="T2">Table 2</xref>). The free energy for the native ligand (OdDHL) binding to the receptor LasR was -115.08 kcal/mol, and the binding free energy for L1, L2 and L3 ranged from -128.65 kcal/mol to -127.51 kcal/mol which is lower than OdDHL. The obtained coulomb energy affinity was significantly higher than the native ligand, -65.27 kcal/mol to -74.75 kcal/mol versus -33.9 kcal/mol, respectively. The compound L1 had the lowest &#x0394;G
                    <sub>Bind</sub> energy, but compound L2 had comparatively better coulomb energy as well as the solvation energy of the complex. The native ligand had more ligand strain energy (SE
                    <sub>Lig</sub>) than the selected compounds.</p>
                <table-wrap id="T2" orientation="portrait" position="float">
                    <label>Table 2. </label>
                    <caption>
                        <title>Prime MM-GBSA (Molecular Mechanics-Generalized Born Surface Area) binding free energy calculation for the three selected compounds.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Compounds</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>Bind</sub> (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>Coul</sub> (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>H-bond</sub> (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>SolvGB</sub> (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">SE
                                    <sub>Lig</sub> (kcal/mol)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L1</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-128.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-65.27</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-2.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">55.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.28</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-127.89</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-74.75</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-2.50</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">58.48</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5.19</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-127.51</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-72.27</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-2.61</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">56.53</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8.04</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">OdDHL</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-115.08</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-33.9</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-1.63</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">24.05</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10.03</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <p>&#x0394;G
                            <sub>Bind</sub> = MM-GBSA free binding energy, &#x0394;G
                            <sub>Coul</sub> = Coulomb energy of the complex, &#x0394;G
                            <sub>H-bond</sub> = Binding energy of H-bond, &#x0394;G
                            <sub>SolvGB</sub> = solvation energy of the complex, SE
                            <sub>Lig</sub> = strain energy of the compounds.</p>
                    </table-wrap-foot>
                </table-wrap>
            </sec>
            <sec id="sec21">
                <title>ADMET and molecular properties</title>
                <p>All three compounds retained satisfactory results with values in the range of 95% of known drugs. The ADMET properties of the selected compounds were within the acceptable range for optimal drug candidates. None of the compounds violated Lipinski&#x2019;s rule of five or Jorgensen&#x2019;s rule of three. The HERG value, central nervous system (CNS) activity, binding to human serum albumin and other properties were within limit. The human oral absorption of the compounds was above 80%. The QPlogHERG values for L1, L2 and L3 were -4.964, -4.59, -3.688 respectively. A value below -5.00 raises concern as to whether the compound might act as hREG inhibitor for K
                    <sup>+</sup> ion channel. Since the L1 compound is close to the threshold level for QPlogHERG value, it must be experimentally checked for hREG inhibition activity. The human oral absorption rate for all three compounds was excellent (&gt;80%) and the compounds did not show acute oral toxicity. The ADMET profile of selected three compounds is provided in 
                    <xref ref-type="table" rid="T3">Table 3</xref>. Furthermore, the molecular descriptors for the compounds were analyzed and shown in 
                    <xref ref-type="table" rid="T4">Table 4</xref>.</p>
                <table-wrap id="T3" orientation="portrait" position="float">
                    <label>Table 3. </label>
                    <caption>
                        <title>The ADMET (absorption, distribution, metabolism, excretion, toxicity) properties of the proposed lead compounds.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">ADMET</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L1</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L2</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L3</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Optimal range (For 95% of known drugs)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">RuleOfFive</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Maximum violation is 4</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">RuleOfThree</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Maximum violation is 3</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPpolrz</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">34.102</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">32.525</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">31.729</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">13.0 to 70.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogPC16</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.072</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.43</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.311</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0.4 to 18.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogPoct</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">17.405</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">18.082</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">17.634</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0.8 to 35.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogPw</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.14</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.325</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">11.275</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4.0 to 45.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogPo/w</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">2.712</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">2.652</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">2.513</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-2.0 to 6.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogS</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.069</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-2.614</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-1.667</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-6.5 to 0.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">CIQPlogS</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.353</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.431</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.431</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-6.5 to 0.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogHERG</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-4.964</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-4.59</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.688</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Concern below -5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPPCaco</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">348.525</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">289.376</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">196.192</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">&lt;25 = poor; &gt;500 = great</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogBB</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.011</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.182</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.319</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.0 to 1.2</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPPMDCK</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">926.158</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">832.435</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">490.056</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">&lt;25 = poor; &gt;500 = great</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogKp</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.496</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.542</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-3.803</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-8.0 to -1.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">QPlogKhsa</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.137</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.222</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-0.224</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">- 1.5 to 1.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">HOA%</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">88.323</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">86.528</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">82.696</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">&lt;25% is poor; &gt;80% is high</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">CNS</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">1</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-2 (inactive); +2 (active)</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <p>Rule of Five = Lipinski&#x2019;s rule of five (MW &lt; 500, logPo/w&lt;5, donorHB &#x2264; 5, accptHB &#x2264; 10); Rule Of Three = Jorgensen&#x2019;s rule of three (logS &gt; -5.7, PCaco &gt; 22, Primary metabolites &lt; 7); QPpolrz = predicted polarizability in cubic angstroms; QPlogPC16 = predicted hexadecane/gas partition coefficient; QPlogPoct = predicted octanol/gas partition coefficient; QPlogPw = predicted water/gas partition coefficient; QPlogPo/w = predicted octanol/water partition coefficient; QPlogS = predicted aqueous solubility; CIQPlogS = conformation-independent predicted aqueous solubility; QPlogHERG = predicted IC50 value for blockage of HERG K
                            <sup>+</sup> channels; QPPCaco = predicted apparent Caco-2 cell permeability in nm/s; QPlogBB = predicted brain/blood partition coefficient; QPPMDCK = predicted apparent MDCK cell permeability in nm/s; QPlogKp = predicted skin permeability; QPlogKhsa = prediction of binding to human serum albumin; HOA% = predicted Human Oral Absorption on 0 to 100% scale; CNS = predicted central nervous system activity on a &#x2013;2 (inactive) to +2 (active) scale.</p>
                    </table-wrap-foot>
                </table-wrap>
                <table-wrap id="T4" orientation="portrait" position="float">
                    <label>Table 4. </label>
                    <caption>
                        <title>Molecular descriptor profiles of the proposed lead compounds.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Molecular properties</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L1</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L2</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">L3</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Optimal range (For 95% of known drugs)</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">mol MW</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">373.307</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">375.323</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">375.323</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">130.0 to 725.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">dipole</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8.017</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.375</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5.925</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.0 to 12.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">SASA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">646.701</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">625.665</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">592.798</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">300 to 1000.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">FOSA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">328.535</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">278.895</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">278.401</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 750.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">FISA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">67.579</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">80.502</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">94.179</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.0 to 330.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">PISA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">159.939</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">159.897</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">130.262</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 450.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">PSA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">57.928</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">62.255</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">67.139</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.0 to 200.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">WPSA</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">90.649</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">106.371</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">89.956</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 175.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">volume</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1096.09</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1088.771</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1092</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">500 to 2000.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">donorHB</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 6.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">accptHB</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">5.25</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4.75</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4.75</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2.0 &#x2013; 20.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">glob</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.794985</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.818051</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.865114</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.75 to 0.95</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">#rtvFG</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 2.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">#metab</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">1.0 to 8.0</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">#ringatoms</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">11</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">6</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">6</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">--</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">IP (eV)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">9.054</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8.83</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">9.17</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">7.9 to 10.5</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">EA (eV)</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.191</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.171</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.358</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-0.9 to 1.7</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">#rotor</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">8</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">10</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">11</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">0.0 to 15.0</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <p>mol MW = Molecular weight of the molecule; dipole = Computed dipole moment of the molecule; SASA = Total solvent accessible surface area; FOSA = Hydrophobic component of SASA; FISA = Hydrophilic component of SASA; PISA = Pi component of SASA; PSA = Van der Waals surface area of polar nitrogen and oxygen atoms; WPSA = Weakly polar component of SASA; volume = Total solvent accessible volume; donorHB = donor-hydrogen bonds; accptHB = acceptor-hydrogen bonds; glob = Globularity descriptor; #rtvFG = Number of reactive functional groups; #metab = Number of likely metabolic reaction; #ringatoms = Number of atoms in a ring; IP (eV) = PM3 calculated ionization potential; EA (eV) = PM3 calculated electron affinity; #rotor = Number of rotatable bonds.</p>
                    </table-wrap-foot>
                </table-wrap>
                <p>No suitable inhibitor was found from ChEMBL and SancDB databases. Despite some compounds having good XP score, all of them were eliminated in the ADMET screening stage. The chemical structures of the L1, L2, L3 and OdDHL are presented in 
                    <xref ref-type="fig" rid="f4">Figure 4</xref>. The compounds lack the ester functional group in the ring implying that there is no lactone headgroup which is the characteristic of the native ligand, OdDHL.</p>
                <fig fig-type="figure" id="f4" orientation="portrait" position="float">
                    <label>Figure 4. </label>
                    <caption>
                        <title>Two-dimensional representation of the selected compounds: (A) L1 compound, (B) L2 compound, (C) L3 compound and (D) the native ligand OdDHL.</title>
                        <p>The L2 and L3 chemical compounds have similar chemical structures with one ring while L1 contains two rings. All selected compounds lack the characteristic lactone headgroup of OdDHL.</p>
                    </caption>
                    <graphic id="gr4" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure4.gif"/>
                </fig>
            </sec>
            <sec id="sec22">
                <title>Molecular dynamics</title>
                <p>Molecular dynamics were run using the LasR_DMC27b protein and the three selected ligands as well as the reference ligand, OdDHL. After 100 ns simulation period, the ligand-protein RMSD (root mean square deviation) results indicated that all three complexes were close to the permissible limit of 3.0 &#x00c5; with respect to the reference ligand complex. However, complex-3 had a value &gt;4.0 &#x00c5; during the 20 ns and later at 95 ns simulation period (
                    <xref ref-type="fig" rid="f5">Figure 5(A)</xref>) and it was not equilibrated until 50 ns. All the complexes were equilibrated after 30 ns and found to be stable, albeit the reference complex was not found to be equilibrated at the beginning but after 80 ns, it had the lowest RMSD, indicating lesser fluctuation and improved stability. Complex-1 has shown superior stability and is closer to the reference complex than the other experimental complexes. In terms of the LasR-DMC27b protein&#x2019;s stability, all three selected ligand-protein complexes were quite stable as they showed an RMSD value lower than 3 &#x00c5;. Compared to all, the complex-2 showed better protein stability (
                    <xref ref-type="fig" rid="f5">Figure 5(B)</xref>). The conformation changes occurring to the protein&#x2019;s side chain were analyzed using the root mean square fluctuation (RMSF) values. Greater fluctuations are usually found in the protein&#x2019;s N-terminal and C-terminal domains, and this was also the case for the LasR-DMC27b protein and the docked complexes. Except for a few spikes, the complexes exhibited low fluctuations overall indicating their potential to be used as antagonist compounds (
                    <xref ref-type="fig" rid="f5">Figure 5(C)</xref>).</p>
                <fig fig-type="figure" id="f5" orientation="portrait" position="float">
                    <label>Figure 5. </label>
                    <caption>
                        <title>Molecular docking simulation analysis of Complex-1 (red), Complex-2 (green), Complex-3 (yellow) and Reference complex (blue):</title>
                        <p>(A) Ligand-protein complex RMSD (root-mean-square deviation), (B) Protein C&#x03b1; RMSD and (C) Protein C&#x03b1; RMSF (root-mean-square fluctuation) of the backbone-atoms of the docked LasR-DMC27b protein.</p>
                    </caption>
                    <graphic id="gr5" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure5.gif"/>
                </fig>
                <p>Using the default parameters of the Desmond module, the MD trajectories of the LasR protein, three possible lead compounds, and the reference complex were analyzed. In protein-ligand interactions, Complex-1, Complex-2, and Complex-3 hydrogen bonded with residues including ASP_73, THR_75, THR_115 and SER_129, while reference complex further formed hydrogen bonds with TYR_56 &amp; TRP_60. Moreover, complex-3 formed hydrogen bonded with TYR_64, TRP_88 &amp; TYR_93 exclusively. There was a weak ionic bond with ASP_73 in complex 3. There were hydrophobic bonds and water bridges present in various residues in all the complexes (
                    <xref ref-type="fig" rid="f6">Figure 6</xref>).</p>
                <fig fig-type="figure" id="f6" orientation="portrait" position="float">
                    <label>Figure 6. </label>
                    <caption>
                        <title>The number of hydrogen, hydrophobic, ionic bonds and water bridges in (A) Complex-1, (B) Complex-2, (C) Complex-3, and (D) Reference complex.</title>
                    </caption>
                    <graphic id="gr6" orientation="portrait" position="float" xlink:href="https://f1000research-files.f1000.com/manuscripts/144597/3d7b4098-41aa-4905-b408-e3290fe985d2_figure6.gif"/>
                </fig>
            </sec>
            <sec id="sec23">
                <title>Post molecular dynamics MMGBSA binding free energy calculation</title>
                <p>In the post-molecular dynamics MMGBSA analysis, out of the three compounds, L2 compound showed lower binding free energy (&#x0394;G
                    <sub>Bind</sub> = -88.97 kcal/mol) than the native ligand (
                    <xref ref-type="table" rid="T5">Table 5</xref>). The &#x0394;G
                    <sub>Bind</sub> free energy for the native ligand (OdDHL) binding to the receptor LasR was -80.58 kcal/mol, and the binding free energy for L1, L2 and L3 compounds ranged from -69.7 kcal/mol to -88.97 kcal/mol. This is lower compared to MMGBSA analysis prior to molecular dynamics which ranged from -128.65 kcal/mol to -127.51 kcal/mol. The compound L2 also had the lowest hydrogen bond energy of the complex as well as the lowest Coulomb energy of the complex. This indicates that L2 compound was a better drug candidate compared to L1 and L3.</p>
                <table-wrap id="T5" orientation="portrait" position="float">
                    <label>Table 5. </label>
                    <caption>
                        <title>Prime MM-GBSA (Molecular Mechanics-Generalized Born Surface Area) binding energy calculation of the potential ligands.</title>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Ligands</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>Bind (kcal/mol)</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>Coul (kcal/mol)</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>HBond (kcal/mol)</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>SolvGB</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>vdW</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">SE
                                    <sub>Lig</sub>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L1</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-74.89</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-49.42</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-1.33</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">50.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-53.02</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2.36</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-88.97</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-69.2</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-3.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">61.23</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-53.38</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">3.638</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">L3</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-69.7</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-52.42</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-1.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">53.59</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-45.84</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2.454</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="middle">OdDHL</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-80.58</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-27.68</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-2.05</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">26.07</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">-57.7</td>
                                <td align="left" colspan="1" rowspan="1" valign="middle">2.899</td>
                            </tr>
                        </tbody>
                    </table>
                    <table-wrap-foot>
                        <p>&#x0394;G
                            <sub>Bind</sub> - MM-GBSA free binding energy; &#x0394;G
                            <sub>Coul</sub> - Coulomb energy of the complex; &#x0394;G
                            <sub>HBond</sub> - Hydrogen Bond energy of the complex; &#x0394;G
                            <sub>SolvGB</sub> - solvation energy of the complex; &#x0394;G
                            <sub>vdW</sub> - van der Waals energy of the complex; and SE
                            <sub>Lig</sub> - strain energy of the ligands. Here, the binding energy unit is kcal/mol.</p>
                    </table-wrap-foot>
                </table-wrap>
            </sec>
            <sec id="sec24">
                <title>Comparative analysis</title>
                <p>Our study reported no major mutation in the LasR protein in 
                    <italic toggle="yes">P. aeruginosa</italic> DMC27b strain that could make it functionally different from the reference strain. We further performed a comparative analysis between the two strains to identify if docking score changes between two proteins due to single amino acid mutation in the terminal region. Our comparative analysis showed that the selected three compounds (L1, L2, and L3) had consistently better binding capacity to both receptors than the native ligand OdDHL. This finding further strengthens the hypothesis that ligand screening in single isolate could be relevant for use in other strains. A further in-depth study could be performed to observe how inhibitors reported by other studies would act against LasR across different strains of 
                    <italic toggle="yes">P. aeruginosa.</italic> 
                    <xref ref-type="table" rid="T6">Table 6</xref> shows the comparison of interaction of selected compounds and the native ligand with both receptors, LasR_DMC27b and 3IX3.</p>
                <table-wrap id="T6" orientation="portrait" position="float">
                    <label>Table 6. </label>
                    <caption>
                        <title>Comparison of receptor-inhibitor complex studies between LasR-DMC-27b and reference protein 3IX3.</title>
                        <p>XP, Extra-Precision.</p>
                    </caption>
                    <table content-type="article-table" frame="hsides">
                        <thead>
                            <tr>
                                <th align="left" colspan="1" rowspan="1" valign="top">Compound</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">&#x0394;G
                                    <sub>Bind (kcal/mol)</sub>
                                </th>
                                <th align="left" colspan="1" rowspan="1" valign="top">XP docking (kcal/mol)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">HB (n)</th>
                                <th align="left" colspan="1" rowspan="1" valign="top">Residues involved in H-bonds</th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td align="left" colspan="5" rowspan="1" valign="middle">Protein: LasR_DMC27b</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L1</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-128.65</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.466</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L2</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-127.89</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.421</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L3</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-127.51</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-11.764</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">OdDHL</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-115.08</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-8.681</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp60</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="5" rowspan="1" valign="top">Reference Protein: 3IX3</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L1</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-124.09</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.372</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Thr75, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L2</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-126.06</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.385</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Thr75, Asp73, Trp88</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">L3</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-128.90</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-12.093</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">3</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73</td>
                            </tr>
                            <tr>
                                <td align="left" colspan="1" rowspan="1" valign="top">OdDHL</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-121.93</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">-10.258</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">4</td>
                                <td align="left" colspan="1" rowspan="1" valign="top">Tyr56, Ser129, Asp73, Trp60</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>Our study has its limitations: first, the research design was based on similarity search to find potential ligands, and this has its inherent limitation that potential inhibitors must be further chemically synthesized and experimented 
                    <italic toggle="yes">in-vitro</italic> for efficacy. Second, we could not perform longer than 100 ns simulation in molecular dynamics due to resource constraints. However, the selected compounds in this study were found to rigidly dock within the binding pocket of the receptor and they had shown higher binding capability to the LasR than the native ligand. The study thus indicates that the docked complexes can be considered as stable compounds for further 
                    <italic toggle="yes">in-vitro</italic> experiments.</p>
            </sec>
        </sec>
        <sec id="sec25" sec-type="conclusions">
            <title>Conclusions</title>
            <p>The clinical isolate 
                <italic toggle="yes">Pseudomonas aeruginosa</italic> DMC-27b has a genetic profile of a complete QS network with biofilm-forming capacity. Three lead compounds that were proposed in this study will likely be generalizable for other 
                <italic toggle="yes">P.aeruginosa</italic> strains due to a lack of significant mutation in the LasR protein. But both 
                <italic toggle="yes">in-vitro</italic> and 
                <italic toggle="yes">in-vivo</italic> studies are required to check for the potentiality of the suggested QSIs. Based on the findings, this study will continue to provide insights for further research in drug designing and development against clinical isolates 
                <italic toggle="yes">of P. aeruginosa</italic> as well as other bacteria that use a similar QS system.</p>
        </sec>
    </body>
    <back>
        <sec id="sec28" sec-type="data-availability">
            <title>Data availability</title>
            <sec id="sec29">
                <title>Underlying data</title>
                <p>GenBank: 
                    <italic toggle="yes">P. aeruginosa</italic> DMC-27b genome. Accession number, SMRY00000000.2; 
                    <ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2">https://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2</ext-link>.</p>
                <p>Protein Data Bank: LasR-OC12 HSL complex used to generate LasR_DMC27b.pdb file at 
                    <ext-link ext-link-type="uri" xlink:href="https://swissmodel.expasy.org/">Swiss Model</ext-link>. Accession number, PD3IX3; 
                    <ext-link ext-link-type="uri" xlink:href="https://www.wwpdb.org/pdb?id=pdb_00003ix3">https://www.wwpdb.org/pdb?id=pdb_00003ix3</ext-link>.</p>
                <p>PubChem: Three druggable candidates used in this study. Accession numbers, 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/119321904">119321904</ext-link>, 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/119321914">119321914</ext-link>, and 
                    <ext-link ext-link-type="uri" xlink:href="https://pubchem.ncbi.nlm.nih.gov/compound/119321910">119321910</ext-link>.</p>
                <p>Figshare: Chemical Library_Potential antagonist of LasR receptor_HSB1900. 
                    <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6084/m9.figshare.22579234.v1">https://doi.org/10.6084/m9.figshare.22579234.v1</ext-link> (
                    <xref ref-type="bibr" rid="ref31">Siam, 2023</xref>).</p>
                <p>This project contains the following underlying data:
                    <list list-type="bullet">
                        <list-item>
                            <label>-</label>
                            <p>Chemical Library_Potential antagonist of LasR receptor (1900 chemical structure files in sdf text-based format).
</p>
                        </list-item>
                    </list>
                </p>
                <p>Data are available under the terms of the 
                    <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution 4.0 International license</ext-link> (CC-BY 4.0).</p>
            </sec>
        </sec>
        <ref-list>
            <title>References</title>
            <ref id="ref1">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Annapoorani</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Umamageswaran</surname>
                            <given-names>V</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Parameswari</surname>
                            <given-names>R</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Computational discovery of putative quorum sensing inhibitors against LasR and RhlR receptor proteins of Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">J. Comput. Aided Mol. Des.</italic>
</source>
                    <year>2012</year>;<volume>26</volume>(<issue>9</issue>):<fpage>1067</fpage>&#x2013;<lpage>1077</lpage>.
                    <pub-id pub-id-type="pmid">22986632</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10822-012-9599-1</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref2">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Banks</surname>
                            <given-names>JL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Beard</surname>
                            <given-names>HS</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cao</surname>
                            <given-names>Y</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Integrated Modeling Program, Applied Chemical Theory (IMPACT).</article-title>
                    <source>

                        <italic toggle="yes">J. Comput. Chem.</italic>
</source>
                    <year>2005</year>;<volume>26</volume>(<issue>16</issue>):<fpage>1752</fpage>&#x2013;<lpage>1780</lpage>.
                    <pub-id pub-id-type="pmid">16211539</pub-id>
                    <pub-id pub-id-type="doi">10.1002/jcc.20292</pub-id>
                    <pub-id pub-id-type="pmcid">PMC2742605</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref3">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Bodey</surname>
                            <given-names>GP</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bolivar</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fainstein</surname>
                            <given-names>V</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Infections caused by Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">Rev. Infect. Dis.</italic>
</source>
                    <year>1983</year>;<volume>5</volume>(<issue>2</issue>):<fpage>279</fpage>&#x2013;<lpage>313</lpage>.
                    <pub-id pub-id-type="doi">10.1093/clinids/5.2.279</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref4">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Davies</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nowotka</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Papadatos</surname>
                            <given-names>G</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>ChEMBL web services: Streamlining access to drug discovery data and utilities.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2015</year>;<volume>43</volume>(<issue>W1</issue>):<fpage>W612</fpage>&#x2013;<lpage>W620</lpage>.
                    <pub-id pub-id-type="pmid">25883136</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkv352</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4489243</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref5">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Feltner</surname>
                            <given-names>JB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Wolter</surname>
                            <given-names>DJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pope</surname>
                            <given-names>CE</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">MBio.</italic>
</source>
                    <year>2016</year>;<volume>7</volume>(<issue>5</issue>).
                    <pub-id pub-id-type="pmid">27703072</pub-id>
                    <pub-id pub-id-type="doi">10.1128/mBio.01513-16</pub-id>
                    <pub-id pub-id-type="pmcid">PMC5050340</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref6">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Friesner</surname>
                            <given-names>RA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Banks</surname>
                            <given-names>JL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Murphy</surname>
                            <given-names>RB</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Glide: A New Approach for Rapid, Accurate Docking and Scoring. 1. Method and Assessment of Docking Accuracy.</article-title>
                    <source>

                        <italic toggle="yes">J. Med. Chem.</italic>
</source>
                    <year>2004</year>;<volume>47</volume>(<issue>7</issue>):<fpage>1739</fpage>&#x2013;<lpage>1749</lpage>.
                    <pub-id pub-id-type="pmid">15027865</pub-id>
                    <pub-id pub-id-type="doi">10.1021/jm0306430</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref7">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hatherley</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Brown</surname>
                            <given-names>DK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Musyoka</surname>
                            <given-names>TM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SANCDB: A South African natural compound database.</article-title>
                    <source>

                        <italic toggle="yes">J. Chem.</italic>
</source>
                    <year>2015</year>;<volume>7</volume>(<issue>1</issue>):<fpage>29</fpage>.
                    <pub-id pub-id-type="pmid">26097510</pub-id>
                    <pub-id pub-id-type="doi">10.1186/s13321-015-0080-8</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4471313</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref8">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Hentzer</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Givskov</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>Pharmacological inhibition of quorum sensing for the treatment of chronic bacterial infections.</article-title>
                    <source>

                        <italic toggle="yes">J. Clin. Invest.</italic>
</source>
                    <year>2003</year>;<volume>112</volume>(<issue>9</issue>):<fpage>1300</fpage>&#x2013;<lpage>1307</lpage>.
                    <pub-id pub-id-type="doi">10.1172/JCI20074</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref9">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ioakimidis</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Thoukydidis</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Mirza</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Benchmarking the Reliability of QikProp. Correlation between Experimental and Predicted Values.</article-title>
                    <source>

                        <italic toggle="yes">QSAR &amp; Comb. Sci.</italic>
</source>
                    <year>2008</year>;<volume>27</volume>(<issue>4</issue>):<fpage>445</fpage>&#x2013;<lpage>456</lpage>.
                    <pub-id pub-id-type="doi">10.1002/qsar.200730051</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref10">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jahan</surname>
                            <given-names>MI</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Rahaman</surname>
                            <given-names>MM</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hossain</surname>
                            <given-names>MA</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Occurrence of intI1-associated VIM-5 carbapenemase and co-existence of all four classes of b-lactamase in carbapenem-resistant clinical Pseudomonas aeruginosa DMC-27b.</article-title>
                    <source>

                        <italic toggle="yes">J. Antimicrob. Chemother.</italic>
</source>
                    <year>2020</year>;<volume>75</volume>(<issue>1</issue>):<fpage>86</fpage>&#x2013;<lpage>91</lpage>.
                    <pub-id pub-id-type="pmid">31647552</pub-id>
                    <pub-id pub-id-type="doi">10.1093/jac/dkz426</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref11">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jakobsen</surname>
                            <given-names>TH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Gennip</surname>
                            <given-names>M</given-names>
                            <prefix>van</prefix>
                        </name>

                        <name name-style="western">
                            <surname>Phipps</surname>
                            <given-names>RK</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ajoene, a Sulfur-Rich Molecule from Garlic, Inhibits Genes Controlled by Quorum Sensing.</article-title>
                    <source>

                        <italic toggle="yes">Antimicrob. Agents Chemother.</italic>
</source>
                    <year>2012</year>;<volume>56</volume>(<issue>5</issue>):<fpage>2314</fpage>&#x2013;<lpage>2325</lpage>.
                    <pub-id pub-id-type="pmid">22314537</pub-id>
                    <pub-id pub-id-type="doi">10.1128/AAC.05919-11</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3346669</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref12">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Jorgensen</surname>
                            <given-names>WL</given-names>
                        </name>
</person-group>:
                    <article-title>The Many Roles of Computation in Drug Discovery.</article-title>
                    <source>

                        <italic toggle="yes">Science.</italic>
</source>
                    <year>2004</year>;<volume>303</volume>(<issue>5665</issue>):<fpage>1813</fpage>&#x2013;<lpage>1818</lpage>.
                    <pub-id pub-id-type="doi">10.1126/science.1096361</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref13">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kalia</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Singh</surname>
                            <given-names>PK</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Yadav</surname>
                            <given-names>VK</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Structure based virtual screening for identification of potential quorum sensing inhibitors against LasR master regulator in Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">Microb. Pathog.</italic>
</source>
                    <year>2017</year>;<volume>107</volume>:<fpage>136</fpage>&#x2013;<lpage>143</lpage>.
                    <pub-id pub-id-type="pmid">28351711</pub-id>
                    <pub-id pub-id-type="doi">10.1016/j.micpath.2017.03.026</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref14">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Kim</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chen</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cheng</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>PubChem 2019 update: Improved access to chemical data.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2019</year>;<volume>47</volume>(<issue>D1</issue>):<fpage>D1102</fpage>&#x2013;<lpage>D1109</lpage>.
                    <pub-id pub-id-type="pmid">30371825</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gky1033</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6324075</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref15">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lee</surname>
                            <given-names>JY</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Zhang</surname>
                            <given-names>L</given-names>
                        </name>
</person-group>:
                    <article-title>The hierarchy quorum sensing network in Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">Protein Cell.</italic>
</source>
                    <year>2014</year>;<volume>6</volume>:<fpage>26</fpage>&#x2013;<lpage>41</lpage>.
                    <pub-id pub-id-type="pmid">25249263</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s13238-014-0100-x</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4286720</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref16">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lipinski</surname>
                            <given-names>CA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lombardo</surname>
                            <given-names>F</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Dominy</surname>
                            <given-names>BW</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.</article-title>
                    <source>

                        <italic toggle="yes">Adv. Drug Deliv. Rev.</italic>
</source>
                    <year>2001</year>;<volume>46</volume>(<issue>1&#x2013;3</issue>):<fpage>3</fpage>&#x2013;<lpage>26</lpage>.
                    <pub-id pub-id-type="pmid">11259830</pub-id>
                    <pub-id pub-id-type="doi">10.1016/s0169-409x(00)00129-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref36">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Liu</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Kokubo</surname>
                            <given-names>H</given-names>
                        </name>
</person-group>:
                    <article-title>Exploring the Stability of Ligand Binding Modes to Proteins by Molecular Dynamics Simulations: A Cross-docking Study.</article-title>
                    <source>

                        <italic toggle="yes">J. Chem. Inf. Model.</italic>
</source>
                    <year>2017</year>;<volume>57</volume>(<issue>10</issue>):<fpage>2514</fpage>&#x2013;<lpage>2522</lpage>.
                    <pub-id pub-id-type="doi">10.1021/acs.jcim.7b00412</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref17">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lyczak</surname>
                            <given-names>JB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cannon</surname>
                            <given-names>CL</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pier</surname>
                            <given-names>GB</given-names>
                        </name>
</person-group>:
                    <article-title>Lung Infections Associated with Cystic Fibrosis.</article-title>
                    <source>

                        <italic toggle="yes">Clin. Microbiol. Rev.</italic>
</source>
                    <year>2002</year>;<volume>15</volume>(<issue>2</issue>):<fpage>194</fpage>&#x2013;<lpage>222</lpage>.
                    <pub-id pub-id-type="pmid">11932230</pub-id>
                    <pub-id pub-id-type="doi">10.1128/CMR.15.2.194-222.2002</pub-id>
                    <pub-id pub-id-type="pmcid">PMC118069</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref18">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Lyne</surname>
                            <given-names>PD</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lamb</surname>
                            <given-names>ML</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Saeh</surname>
                            <given-names>JC</given-names>
                        </name>
</person-group>:
                    <article-title>Accurate prediction of the relative potencies of members of a series of kinase inhibitors using molecular docking and MM-GBSA scoring.</article-title>
                    <source>

                        <italic toggle="yes">J. Med. Chem.</italic>
</source>
                    <year>2006</year>;<volume>49</volume>(<issue>16</issue>):<fpage>4805</fpage>&#x2013;<lpage>4808</lpage>.
                    <pub-id pub-id-type="pmid">16884290</pub-id>
                    <pub-id pub-id-type="doi">10.1021/jm060522a</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref35">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Mark</surname>
                            <given-names>P</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Nilsson</surname>
                            <given-names>L</given-names>
                        </name>
</person-group>:
                    <article-title>Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K.</article-title>
                    <source>

                        <italic toggle="yes">J. Phys. Chem. A.</italic>
</source>
                    <year>2001</year>;<volume>105</volume>(<issue>43</issue>):<fpage>9954</fpage>&#x2013;<lpage>9960</lpage>.
                    <pub-id pub-id-type="doi">10.1021/jp003020w</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref19">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Monte</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Abreu</surname>
                            <given-names>AC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Borges</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Antimicrobial Activity of Selected Phytochemicals against Escherichia coli and Staphylococcus aureus and Their Biofilms.</article-title>
                    <source>

                        <italic toggle="yes">Pathogens.</italic>
</source>
                    <year>2014</year>;<volume>3</volume>(<issue>2</issue>):<fpage>473</fpage>&#x2013;<lpage>498</lpage>.
                    <pub-id pub-id-type="pmid">25437810</pub-id>
                    <pub-id pub-id-type="doi">10.3390/pathogens3020473</pub-id>
                    <pub-id pub-id-type="pmcid">PMC4243457</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref20">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Nain</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sayed</surname>
                            <given-names>SB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Karim</surname>
                            <given-names>MM</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Energy-optimized pharmacophore coupled virtual screening in the discovery of quorum sensing inhibitors of LasR protein of Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">J. Biomol. Struct. Dyn.</italic>
</source>
                    <year>2019</year>;<volume>38</volume>:<fpage>5374</fpage>&#x2013;<lpage>5388</lpage>.
                    <pub-id pub-id-type="pmid">31787031</pub-id>
                    <pub-id pub-id-type="doi">10.1080/07391102.2019.1700168</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref21">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Ochsner</surname>
                            <given-names>UA</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Reiser</surname>
                            <given-names>J</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Fiechter</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Production of Pseudomonas aeruginosa Rhamnolipid Biosurfactants in Heterologous Hosts.</article-title>
                    <source>

                        <italic toggle="yes">Appl. Environ. Microbiol.</italic>
</source>
                    <year>1995</year>;<volume>61</volume>(<issue>9</issue>):<fpage>3503</fpage>&#x2013;<lpage>3506</lpage>.
                    <pub-id pub-id-type="pmid">16535135</pub-id>
                    <pub-id pub-id-type="doi">10.1128/aem.61.9.3503-3506.1995</pub-id>
                    <pub-id pub-id-type="pmcid">PMC1388589</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref22">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>O&#x2019;Loughlin</surname>
                            <given-names>CT</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Miller</surname>
                            <given-names>LC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Siryaporn</surname>
                            <given-names>A</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>A quorum-sensing inhibitor blocks Pseudomonas aeruginosa virulence and biofilm formation.</article-title>
                    <source>

                        <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic>
</source>
                    <year>2013</year>;<volume>110</volume>(<issue>44</issue>):<fpage>17981</fpage>&#x2013;<lpage>17986</lpage>.
                    <pub-id pub-id-type="pmid">24143808</pub-id>
                    <pub-id pub-id-type="doi">10.1073/pnas.1316981110</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3816427</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref23">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Overbeek</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Olson</surname>
                            <given-names>R</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Pusch</surname>
                            <given-names>GD</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST).</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2014</year>;<volume>42</volume>(<issue>Database issue</issue>):<fpage>D206</fpage>&#x2013;<lpage>D214</lpage>.
                    <pub-id pub-id-type="pmid">24293654</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gkt1226</pub-id>
                    <pub-id pub-id-type="pmcid">PMC3965101</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref24">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Paczkowski</surname>
                            <given-names>JE</given-names>
                        </name>

                        <name name-style="western">
                            <surname>McCready</surname>
                            <given-names>AR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cong</surname>
                            <given-names>J-P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>An Autoinducer Analogue Reveals an Alternative Mode of Ligand Binding for the LasR Quorum-Sensing Receptor.</article-title>
                    <source>

                        <italic toggle="yes">ACS Chem. Biol.</italic>
</source>
                    <year>2019</year>;<volume>14</volume>(<issue>3</issue>):<fpage>378</fpage>&#x2013;<lpage>389</lpage>.
                    <pub-id pub-id-type="pmid">30763066</pub-id>
                    <pub-id pub-id-type="doi">10.1021/acschembio.8b00971</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6601336</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref37">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Paul</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Limon</surname>
                            <given-names>BH</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Hossain</surname>
                            <given-names>M</given-names>
                        </name>
</person-group>:
                    <article-title>An integrated computational approach to screening of alkaloids inhibitors of TBX3 in breast cancer cell lines.</article-title>
                    <source>

                        <italic toggle="yes">J. Biomol. Struct. Dyn.</italic>
</source>
                    <year>2023</year>;<volume>41</volume>(<issue>7</issue>):<fpage>3025</fpage>&#x2013;<lpage>3041</lpage>.
                    <pub-id pub-id-type="doi">10.1080/07391102.2022.2046166</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref25">
                <mixed-citation publication-type="other">
                    <collab>Pseudomonas aeruginosa strain DMC-27b, whole genome shotgun sequencing project (1644956224)</collab>:
                    <article-title>NCBI Nucleotide Database.</article-title>
                    <year>2019</year>.
                    <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/SMRY00000000.2">Reference Source</ext-link>
                </mixed-citation>
            </ref>
            <ref id="ref26">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Rasmussen</surname>
                            <given-names>TB</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Skindersoe</surname>
                            <given-names>ME</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bjarnsholt</surname>
                            <given-names>T</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Identity and effects of quorum-sensing inhibitors produced by Penicillium species.</article-title>
                    <source>

                        <italic toggle="yes">Microbiology.</italic>
</source>
                    <year>2005</year>;<volume>151</volume>(<issue>Pt 5</issue>):<fpage>1325</fpage>&#x2013;<lpage>1340</lpage>.
                    <pub-id pub-id-type="pmid">15870443</pub-id>
                    <pub-id pub-id-type="doi">10.1099/mic.0.27715-0</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref27">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Richards</surname>
                            <given-names>MJ</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Edwards</surname>
                            <given-names>JR</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Culver</surname>
                            <given-names>DH</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System.</article-title>
                    <source>

                        <italic toggle="yes">Crit. Care Med.</italic>
</source>
                    <year>1999</year>;<volume>27</volume>(<issue>5</issue>):<fpage>887</fpage>&#x2013;<lpage>892</lpage>.
                    <pub-id pub-id-type="doi">10.1097/00003246-199905000-00020</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref28">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Sarabhai</surname>
                            <given-names>S</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Harjai</surname>
                            <given-names>K</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Sharma</surname>
                            <given-names>P</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Ellagic acid derivatives from Terminalia chebula Retz. Increase the susceptibility of Pseudomonas aeruginosa to stress by inhibiting polyphosphate kinase.</article-title>
                    <source>

                        <italic toggle="yes">J. Appl. Microbiol.</italic>
</source>
                    <year>2015</year>;<volume>118</volume>(<issue>4</issue>):<fpage>817</fpage>&#x2013;<lpage>825</lpage>.
                    <pub-id pub-id-type="pmid">25640983</pub-id>
                    <pub-id pub-id-type="doi">10.1111/jam.12733</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref29">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Scoffone</surname>
                            <given-names>VC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Trespidi</surname>
                            <given-names>G</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Chiarelli</surname>
                            <given-names>LR</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Quorum Sensing as Antivirulence Target in Cystic Fibrosis Pathogens.</article-title>
                    <source>

                        <italic toggle="yes">Int. J. Mol. Sci.</italic>
</source>
                    <year>2019</year>;<volume>20</volume>(<issue>8</issue>).
                    <pub-id pub-id-type="pmid">31013936</pub-id>
                    <pub-id pub-id-type="doi">10.3390/ijms20081838</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6515091</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref30">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Shelley</surname>
                            <given-names>JC</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cholleti</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Frye</surname>
                            <given-names>LL</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Epik: A software program for pKaprediction and protonation state generation for drug-like molecules.</article-title>
                    <source>

                        <italic toggle="yes">J. Comput. Aided Mol. Des.</italic>
</source>
                    <year>2007</year>;<volume>21</volume>(<issue>12</issue>):<fpage>681</fpage>&#x2013;<lpage>691</lpage>.
                    <pub-id pub-id-type="pmid">17899391</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s10822-007-9133-z</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref31">
                <mixed-citation publication-type="data">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Siam</surname>
                            <given-names>MHB</given-names>
                        </name>
</person-group>:
                    <data-title>Chemical Library_Potential antagonist of LasR receptor_HSB1900.</data-title>[dataset].
                    <source>

                        <italic toggle="yes">figshare.</italic>
</source>
                    <year>2023</year>.
                    <pub-id pub-id-type="doi">10.6084/m9.figshare.22579234.v1</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref32">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Solano</surname>
                            <given-names>C</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Echeverz</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Lasa</surname>
                            <given-names>I</given-names>
                        </name>
</person-group>:
                    <article-title>Biofilm dispersion and quorum sensing.</article-title>
                    <source>

                        <italic toggle="yes">Curr. Opin. Microbiol.</italic>
</source>
                    <year>2014</year>;<volume>18</volume>:<fpage>96</fpage>&#x2013;<lpage>104</lpage>.
                    <pub-id pub-id-type="doi">10.1016/j.mib.2014.02.008</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref33">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Waterhouse</surname>
                            <given-names>A</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bertoni</surname>
                            <given-names>M</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Bienert</surname>
                            <given-names>S</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>SWISS-MODEL: Homology modelling of protein structures and complexes.</article-title>
                    <source>

                        <italic toggle="yes">Nucleic Acids Res.</italic>
</source>
                    <year>2018</year>;<volume>46</volume>(<issue>W1</issue>):<fpage>W296</fpage>&#x2013;<lpage>W303</lpage>.
                    <pub-id pub-id-type="pmid">29788355</pub-id>
                    <pub-id pub-id-type="doi">10.1093/nar/gky427</pub-id>
                    <pub-id pub-id-type="pmcid">PMC6030848</pub-id>
                </mixed-citation>
            </ref>
            <ref id="ref34">
                <mixed-citation publication-type="journal">
                    <person-group person-group-type="author">

                        <name name-style="western">
                            <surname>Zeng</surname>
                            <given-names>Z</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Qian</surname>
                            <given-names>L</given-names>
                        </name>

                        <name name-style="western">
                            <surname>Cao</surname>
                            <given-names>L</given-names>
                        </name>

                        <etal/>
</person-group>:
                    <article-title>Virtual screening for novel quorum sensing inhibitors to eradicate biofilm formation of Pseudomonas aeruginosa.</article-title>
                    <source>

                        <italic toggle="yes">Appl. Microbiol. Biotechnol.</italic>
</source>
                    <year>2008</year>;<volume>79</volume>(<issue>1</issue>):<fpage>119</fpage>&#x2013;<lpage>126</lpage>.
                    <pub-id pub-id-type="pmid">18330563</pub-id>
                    <pub-id pub-id-type="doi">10.1007/s00253-008-1406-5</pub-id>
                </mixed-citation>
            </ref>
        </ref-list>
    </back>
    <sub-article article-type="reviewer-report" id="report274961">
        <front-stub>
            <article-id pub-id-type="doi">10.5256/f1000research.144597.r274961</article-id>
            <title-group>
                <article-title>Reviewer response for version 1</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Shaw</surname>
                        <given-names>Sudipta</given-names>
                    </name>
                    <xref ref-type="aff" rid="r274961a1">1</xref>
                    <role>Referee</role>
                    <uri content-type="orcid">https://orcid.org/0000-0002-9127-0959</uri>
                </contrib>
                <aff id="r274961a1">
                    <label>1</label>University of Minnesota, Minnesota, USA</aff>
            </contrib-group>
            <author-notes>
                <fn fn-type="conflict">
                    <p>
                        <bold>Competing interests: </bold>No competing interests were disclosed.</p>
                </fn>
            </author-notes>
            <pub-date pub-type="epub">
                <day>19</day>
                <month>6</month>
                <year>2024</year>
            </pub-date>
            <permissions>
                <copyright-statement>Copyright: &#x00a9; 2024 Shaw S</copyright-statement>
                <copyright-year>2024</copyright-year>
                <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
                    <license-p>This is an open access peer review report distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
                </license>
            </permissions>
            <related-article ext-link-type="doi" id="relatedArticleReport274961" related-article-type="peer-reviewed-article" xlink:href="10.12688/f1000research.131728.1"/>
            <custom-meta-group>
                <custom-meta>
                    <meta-name>recommendation</meta-name>
                    <meta-value>approve</meta-value>
                </custom-meta>
            </custom-meta-group>
        </front-stub>
        <body>
            <p>Antibiotic resistance has become a pressing global health problem and bacterial quorum-sensing plays a significant role in it. Authors of this manuscript have focused on quorum-quenching of a multi-drug resistant clinal isolate of&#x00a0;
                <italic>Pseudomonas aeruginosa</italic>&#x00a0;DMC-27b. They have identified 3 potential inhibitor molecules through a multiple&#x00a0;
                <italic>in silico </italic>screening process. Although there are several limitations of this study as those have been rightfully pointed out by the authors themselves, however, those 3 compounds do seem genuine candidates for future 
                <italic>in-vitro</italic> and eventually 
                <italic>in-vivo</italic> studies.&#x00a0;</p>
            <p> This is a nicely written manuscript with proper scientific evidence and I would recommend that it should be published in this journal.</p>
            <p> I would just like to point out that some of the figures are hard to read, especially the amino acid labels on Figure 3 are quite small and there are some minor irregularities between the images, such as using arrows and lines for the insets in the same panel. Authors should modify those accordingly.</p>
            <p>Is the work clearly and accurately presented and does it cite the current literature?</p>
            <p>Yes</p>
            <p>If applicable, is the statistical analysis and its interpretation appropriate?</p>
            <p>I cannot comment. A qualified statistician is required.</p>
            <p>Are all the source data underlying the results available to ensure full reproducibility?</p>
            <p>Yes</p>
            <p>Is the study design appropriate and is the work technically sound?</p>
            <p>Yes</p>
            <p>Are the conclusions drawn adequately supported by the results?</p>
            <p>Yes</p>
            <p>Are sufficient details of methods and analysis provided to allow replication by others?</p>
            <p>Yes</p>
            <p>Reviewer Expertise:</p>
            <p>I am a trained microbiologist and protein biochemist.</p>
            <p>I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.</p>
        </body>
    </sub-article>
</article>
